Value proposition

Digital retinal imaging software that makes it easy for care providers and diabetic patients to prioritize eye care.

Intelligent Retinal Imaging Systems (IRIS) is the industry leader in the early detection of diabetic retinopathy and other retinal pathologies.

IRIS clients have the freedom to choose their equipment from a variety of cameras that range in price and portability. Our solution integrates with any EMR platform, establishing a seamless integration. Customers receive hands-on training to ensure their program is structured for success. Our end-to-end diagnostic solution is designed to work within a variety of non-traditional eyecare settings and helps to increase access and create better outcomes for diabetic patients while your organization closes care gaps and achieves quality measures/HEDIS compliance.

IRIS was founded in 2011 by nationally recognized retina surgeon Dr. Sunil Gupta, with a vision to end preventable blindness through the development and deployment of retinal diagnostic services in the primary care setting. The IRIS team of physicians, technicians and best practice client success experts partner with forward-thinking providers and payers to enhance patient outcomes by closing care gaps in healthcare systems.

IRIS is the recipient of the 2020 Microsoft AI for Health Award, 2017 Microsoft Innovation Award, and the 2016 Frost & Sullivan New Product Innovation Award in Diabetic Retinopathy. For additional information, visit www.retinalscreenings.com.

Diabetic Retinopathy, retina exams, telemedicine, cloud-based software, diabetic eye disease, artificial intelligence, AI, healthcare technology, healthcare software, diabetic retinopathy diagnostic solution, retinal imaging, ophthalmology, innovation, healthcare IT, Healthcare Innovation, accesstocare, populationhealth, HEDIS, and QualityCare